Nyxoah (NASDAQ:NYXH) Upgraded at Cantor Fitzgerald

Cantor Fitzgerald upgraded shares of Nyxoah (NASDAQ:NYXH) to a strong-buy rating in a research note published on Wednesday morning,Zacks.com reports.

NYXH has been the subject of a number of other reports. Piper Sandler reiterated an “overweight” rating and set a $9.00 price target (down from $12.00) on shares of Nyxoah in a report on Friday, November 14th. Stifel Nicolaus dropped their price objective on Nyxoah from $12.00 to $11.00 and set a “buy” rating on the stock in a research note on Thursday, January 29th. Finally, Weiss Ratings restated a “sell (d-)” rating on shares of Nyxoah in a research report on Monday, December 29th. One equities research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $11.67.

Nyxoah Price Performance

Shares of NASDAQ NYXH opened at $3.74 on Wednesday. Nyxoah has a twelve month low of $3.65 and a twelve month high of $11.87. The firm has a fifty day simple moving average of $4.63 and a 200 day simple moving average of $5.05. The company has a market capitalization of $127.38 million, a PE ratio of -1.50 and a beta of 1.56. The company has a quick ratio of 1.41, a current ratio of 1.70 and a debt-to-equity ratio of 0.40.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of the stock. Franklin Resources Inc. grew its holdings in Nyxoah by 0.9% in the second quarter. Franklin Resources Inc. now owns 294,990 shares of the company’s stock worth $2,207,000 after purchasing an additional 2,655 shares during the period. Bank of America Corp DE raised its holdings in shares of Nyxoah by 72.4% during the second quarter. Bank of America Corp DE now owns 7,866 shares of the company’s stock valued at $59,000 after purchasing an additional 3,303 shares during the period. Raymond James Financial Inc. boosted its position in shares of Nyxoah by 35.6% during the 3rd quarter. Raymond James Financial Inc. now owns 12,762 shares of the company’s stock worth $59,000 after purchasing an additional 3,353 shares in the last quarter. Deutsche Bank AG boosted its position in shares of Nyxoah by 40.0% during the 4th quarter. Deutsche Bank AG now owns 35,000 shares of the company’s stock worth $161,000 after purchasing an additional 10,000 shares in the last quarter. Finally, Rossmore Private Capital grew its stake in shares of Nyxoah by 12.6% in the 3rd quarter. Rossmore Private Capital now owns 132,746 shares of the company’s stock valued at $616,000 after buying an additional 14,806 shares during the period.

About Nyxoah

Nyxoah SA, headquartered in Mont-Saint-Guibert, Belgium, is a medical technology company focused on neuromodulation therapies for sleep‐disordered breathing. Established in 2018, the company’s primary offering is the Genio® system, a minimally invasive bilateral hypoglossal nerve stimulator designed to treat moderate to severe obstructive sleep apnea (OSA). By electrically stimulating the genioglossus muscle, the device helps maintain airway patency during sleep, reducing apnea events and improving overall sleep quality.

The Genio system comprises a small, implantable stimulator positioned submentally and an external activation unit worn by the patient.